<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33587281</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>12</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1931-7565</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>5</Issue><PubDate><Year>2021</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Brain imaging and behavior</Title><ISOAbbreviation>Brain Imaging Behav</ISOAbbreviation></Journal><ArticleTitle>Regional prefrontal cortical atrophy predicts specific cognitive-behavioral symptoms in ALS-FTD.</ArticleTitle><Pagination><StartPage>2540</StartPage><EndPage>2551</EndPage><MedlinePgn>2540-2551</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11682-021-00456-1</ELocationID><Abstract><AbstractText>Amyotrophic Lateral Sclerosis-Frontotemporal Dementia (ALS-FTD) may present typical behavioral variant FTD symptoms. This study aims to determine whether profile and severity of cognitive-behavioral symptoms in ALS/ALS-FTD are predicted by regional cortical atrophy. The hypothesis is that executive dysfunction can be predicted by dorsolateral prefrontal cortical (dlPFC) atrophy, apathy by dorsomedial PFC (dmPFC) and anterior cingulate cortical (ACC) atrophy, disinhibition by orbitofrontal cortical (OFC) atrophy. 3.0 Tesla MRI scans were acquired from 22 people with ALS or ALS-FTD. Quantitative cortical thickness analysis was performed with FreeSurfer. A priori-defined regions of interest (ROI) were used to measure cortical thickness in each participant and calculate magnitude of atrophy in comparison to 115 healthy controls. Spearman correlations were used to evaluate associations between frontal ROI cortical thickness and cognitive-behavioral symptoms, measured by Neuropsychiatric Inventory Questionnaire (NPI-Q) and Clinical Dementia Rating (CDR) scale. ALS-FTD participants exhibited variable degrees of apathy (NPI-Q/apathy: 1.6&#x2009;&#xb1;&#x2009;1.2), disinhibition (NPI-Q/disinhibition: 1.2&#x2009;&#xb1;&#x2009;1.2), executive dysfunction (CDR/judgment-problem solving: 1.7&#x2009;&#xb1;&#x2009;0.8). Within the ALS-FTD group, executive dysfunction correlated with dlPFC atrophy (&#x3c1;:-0.65;p&#x2009;&lt;&#x2009;0.05); similar trends were seen for apathy with ACC (&#x3c1;:-0.53;p&#x2009;&lt;&#x2009;0.10) and dmPFC (&#x3c1;:-0.47;p&#x2009;&lt;&#x2009;0.10) atrophy, for disinhibition with OFC atrophy (&#x3c1;:-0.51;p&#x2009;&lt;&#x2009;0.10). Compared to people with ALS, those with ALS-FTD showed more diffuse atrophy involving precentral gyrus, prefrontal, temporal regions. Profile and severity of cognitive-behavioral symptoms in ALS-FTD are predicted by regional prefrontal atrophy. These findings are consistent with established brain-behavior models and support the role of quantitative MRI in diagnosis, management, counseling, monitoring and prognostication for a neurodegenerative disorder with diverse phenotypes.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ratti</LastName><ForeName>Elena</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-9321-7908</Identifier><AffiliationInfo><Affiliation>Neurological Clinical Research Institute (NCRI), Massachusetts General Hospital, 165 Cambridge Street, Suite 600, Boston, MA, 02114, USA. elena.ratti@alumni.harvard.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Frontotemporal Disorders Unit, Department of Neurology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA. elena.ratti@alumni.harvard.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amyotrophic Lateral Sclerosis Multidisciplinary Clinic, Department of Neurology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA. elena.ratti@alumni.harvard.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Massachusetts Alzheimer's Disease Research Center (ADRC), 149 13th Street, Charlestown, MA, 02129, USA. elena.ratti@alumni.harvard.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Athinoula A. Martinos Center for Biomedical Imaging, 149 13th Street, Charlestown, MA, 02129, USA. elena.ratti@alumni.harvard.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Biogen, 300 Binney Street, Cambridge, MA, 02142, USA. elena.ratti@alumni.harvard.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Domoto-Reilly</LastName><ForeName>Kimiko</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Frontotemporal Disorders Unit, Department of Neurology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Massachusetts Alzheimer's Disease Research Center (ADRC), 149 13th Street, Charlestown, MA, 02129, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Athinoula A. Martinos Center for Biomedical Imaging, 149 13th Street, Charlestown, MA, 02129, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University of Washington Medical Center, 1959 NE Pacific Street, Seattle, WA, 98195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caso</LastName><ForeName>Christina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Frontotemporal Disorders Unit, Department of Neurology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University of Washington Medical Center, 1959 NE Pacific Street, Seattle, WA, 98195, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Murphy</LastName><ForeName>Alyssa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Neurological Clinical Research Institute (NCRI), Massachusetts General Hospital, 165 Cambridge Street, Suite 600, Boston, MA, 02114, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amyotrophic Lateral Sclerosis Multidisciplinary Clinic, Department of Neurology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brickhouse</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Frontotemporal Disorders Unit, Department of Neurology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hochberg</LastName><ForeName>Daisy</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Frontotemporal Disorders Unit, Department of Neurology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Speech and Language Pathology, Massachusetts General Hospital, 275 Cambridge Street, Boston, MA, 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Makris</LastName><ForeName>Nikos</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cudkowicz</LastName><ForeName>Merit E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Neurological Clinical Research Institute (NCRI), Massachusetts General Hospital, 165 Cambridge Street, Suite 600, Boston, MA, 02114, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amyotrophic Lateral Sclerosis Multidisciplinary Clinic, Department of Neurology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dickerson</LastName><ForeName>Bradford C</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>Frontotemporal Disorders Unit, Department of Neurology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Massachusetts Alzheimer's Disease Research Center (ADRC), 149 13th Street, Charlestown, MA, 02129, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Athinoula A. Martinos Center for Biomedical Imaging, 149 13th Street, Charlestown, MA, 02129, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R25 NS065743</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG066957</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG062421</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 AG005134</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG066509</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 EB016449</GrantID><Acronym>EB</Acronym><Agency>NIBIB NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>Dr. Anne B. Young Neuroscience Translational Medicine Fellowship (Massachusetts General Hospital Neurology and Biogen)</GrantID><Agency>Massachusetts General Hospital</Agency><Country/></Grant><Grant><GrantID>R01 AG030311</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 NS079905</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AG030311</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AG063911</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>MGH Neurology Clinical Research Institute, Massachusetts ADRC and Harvard NeuroDiscovery Center's 2013 Pilot Award Program</GrantID><Agency>Massachusetts General Hospital</Agency><Country/></Grant><Grant><GrantID>P01 AG005134</GrantID><Agency>National Institute of Neurological Disorders and Stroke (US)</Agency><Country/></Grant><Grant><GrantID>R01 AG042512</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 NS077059</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>02</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Brain Imaging Behav</MedlineTA><NlmUniqueID>101300405</NlmUniqueID><ISSNLinking>1931-7557</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001284" MajorTopicYN="N">Atrophy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001526" MajorTopicYN="N">Behavioral Symptoms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="N">Magnetic Resonance Imaging</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis (4)</Keyword><Keyword MajorTopicYN="N">Cerebral cortex (2)</Keyword><Keyword MajorTopicYN="N">Frontal lobe (5)</Keyword><Keyword MajorTopicYN="N">Frontotemporal dementia (3)</Keyword><Keyword MajorTopicYN="N">Magnetic resonance imaging (1)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>1</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>2</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>2</Month><Day>15</Day><Hour>12</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33587281</ArticleId><ArticleId IdType="mid">NIHMS1770378</ArticleId><ArticleId IdType="pmc">PMC8862734</ArticleId><ArticleId IdType="doi">10.1007/s11682-021-00456-1</ArticleId><ArticleId IdType="pii">10.1007/s11682-021-00456-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abidi M, Marco G, Couillandre A, Feron M, Mseddi E, Termoz N, Querin G, Pradat PF, &amp; Bede P. (2020). Adaptive functional reorganization in amyotrophic lateral sclerosis: Coexisting degenerative and compensatory changes. European Journal of Neurology, 27(1), 121&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pubmed">31310452</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrahams S, et al. (1996). Frontal lobe dysfunction in amyotrophic lateral sclerosis. A PET study. Brain, 119(Pt 6), 2105&#x2013;2120.</Citation><ArticleIdList><ArticleId IdType="pubmed">9010014</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrahams S, Newton J, Niven E, Foley J, &amp; Bak TH (2014). Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener, 15(1&#x2013;2), 9&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">23781974</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F, Pagani E, Petrolini M, Caputo D, Perini M, Prelle A, Salvi F, &amp; Filippi M. (2010). Assessment of white matter tract damage in patients with amyotrophic lateral sclerosis: A diffusion tensor MR imaging tractography study. AJNR. American Journal of Neuroradiology, 31(8), 1457&#x2013;1461.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7966122</ArticleId><ArticleId IdType="pubmed">20395382</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F, Valsasina P, Riva N, Copetti M, Messina MJ, Prelle A, Comi G, &amp; Filippi M. (2012). The cortical signature of amyotrophic lateral sclerosis. PLoS One, 7(8), e42816.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3412820</ArticleId><ArticleId IdType="pubmed">22880116</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakkour A, Morris JC, &amp; Dickerson BC (2009). The cortical signature of prodromal AD: Regional thinning predicts mild AD dementia. Neurology, 72(12), 1048&#x2013;1055.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2677470</ArticleId><ArticleId IdType="pubmed">19109536</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, &amp; Hardiman O. (2018). Longitudinal structural changes in ALS: A three time-point imaging study of white and gray matter degeneration. Amyotroph Lateral Scler Frontotemporal Degener, 19(3&#x2013;4), 232&#x2013;241.</Citation><ArticleIdList><ArticleId IdType="pubmed">29214883</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Elamin M, Byrne S, McLaughlin RL, Kenna K, Vajda A, Pender N, Bradley DG, &amp; Hardiman O. (2013). Basal ganglia involvement in amyotrophic lateral sclerosis. Neurology, 81(24), 2107&#x2013;2115.</Citation><ArticleIdList><ArticleId IdType="pubmed">24212388</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Elamin M, Byrne S, McLaughlin RL, Kenna K, Vajda A, Fagan A, Bradley DG, &amp; Hardiman O. (2015). Patterns of cerebral and cerebellar white matter degeneration in ALS. Journal of Neurology, Neurosurgery, and Psychiatry, 86(4), 468&#x2013;470.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4392231</ArticleId><ArticleId IdType="pubmed">25053771</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Iyer PM, Schuster C, Elamin M, Mclaughlin RL, Kenna K, &amp; Hardiman O. (2016). The selective anatomical vulnerability of ALS: &#x2018;disease-defining&#x2019; and &#x2018;disease-defying&#x2019; brain regions. Amyotroph Lateral Scler Frontotemporal Degener, 17(7&#x2013;8), 561&#x2013;570.</Citation><ArticleIdList><ArticleId IdType="pubmed">27087114</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Iyer PM, Finegan E, Omer T, &amp; Hardiman O. (2017). Virtual brain biopsies in amyotrophic lateral sclerosis: Diagnostic classification based on in vivo pathological patterns. NeuroImage: Clinical, 15, 653&#x2013;658.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5479963</ArticleId><ArticleId IdType="pubmed">28664036</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Omer T, Finegan E, Chipika RH, Iyer PM, Doherty MA, Vajda A, Pender N, McLaughlin RL, Hutchinson S, &amp; Hardiman O. (2018a). Connectivity-based characterisation of subcortical grey matter pathology in frontotemporal dementia and ALS: A multimodal neuroimaging study. Brain Imaging and Behavior, 12(6), 1696&#x2013;1707.</Citation><ArticleIdList><ArticleId IdType="pubmed">29423814</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Querin G, &amp; Pradat PF (2018b). The changing landscape of motor neuron disease imaging: The transition from descriptive studies to precision clinical tools. Current Opinion in Neurology, 31(4), 431&#x2013;438.</Citation><ArticleIdList><ArticleId IdType="pubmed">29750730</ArticleId></ArticleIdList></Reference><Reference><Citation>Bede P, Chipika RH, Finegan E, Li Hi Shing S, Doherty MA, Hengeveld JC, Vajda A, Hutchinson S, Donaghy C, McLaughlin RL, &amp; Hardiman O. (2019). Brainstem pathology in amyotrophic lateral sclerosis and primary lateral sclerosis: A longitudinal neuroimaging study. NeuroImage: Clinical, 24, 102054.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6849418</ArticleId><ArticleId IdType="pubmed">31711033</ArticleId></ArticleIdList></Reference><Reference><Citation>Beeldman E, Raaphorst J, Klein Twennaar M, de Visser M, Schmand BA, &amp; de Haan RJ (2016). The cognitive profile of ALS: A systematic review and meta-analysis update. Journal of Neurology, Neurosurgery, and Psychiatry, 87(6), 611&#x2013;619.</Citation><ArticleIdList><ArticleId IdType="pubmed">26283685</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H, Patin F, Descat A, Gar&#xe7;on G, Corcia P, Gel&#xe9; P, Lenglet T, Bede P, Meininger V, Devos D, Gossens JF, &amp; Pradat PF (2018). A pharmaco-metabolomics approach in a clinical trial of ALS: Identification of predictive markers of progression. PLoS One, 13(6), e0198116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5988280</ArticleId><ArticleId IdType="pubmed">29870556</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonelli RM, &amp; Cummings JL (2007). Frontal-subcortical circuitry and behavior. Dialogues in Clinical Neuroscience, 9(2), 141&#x2013;151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3181854</ArticleId><ArticleId IdType="pubmed">17726913</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, Libon DJ, Toledo JB, Xie SX, McCluskey L, Elman L, Geser F, Lee VMY, Grossman M, &amp; Trojanowski JQ (2012). Microglial activation and TDP-43 pathology correlate with executive dysfunction in amyotrophic lateral sclerosis. Acta Neuropathologica, 123(3), 395&#x2013;407.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3595560</ArticleId><ArticleId IdType="pubmed">22210083</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, &amp; Munsat TL (2000). El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, 1(5), 293&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke T, Pinto-Grau M, Lonergan K, Elamin M, Bede P, Costello E, Hardiman O, &amp; Pender N. (2016a). Measurement of social cognition in amyotrophic lateral sclerosis: A population based study. PLoS One, 11(8), e0160850.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4996502</ArticleId><ArticleId IdType="pubmed">27556398</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke T, et al. (2016b). Discordant performance on the &#x2018;Reading the Mind in the Eyes&#x2019; Test, based on disease onset in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener, 17(7&#x2013;8):467&#x2013;472.</Citation><ArticleIdList><ArticleId IdType="pubmed">27152765</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke T, Pinto-Grau M, Lonergan K, Bede P, O&#x2019;Sullivan M, Heverin M, Vajda A, McLaughlin RL, Pender N, &amp; Hardiman O. (2017). A cross-sectional population-based investigation into behavioral change in amyotrophic lateral sclerosis: Subphenotypes, staging, cognitive predictors, and survival. Annals of Clinical Translational Neurology, 4(5), 305&#x2013;317.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5420811</ArticleId><ArticleId IdType="pubmed">28491898</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, &amp; Nakanishi A. (1999). The ALSFRS-R: A revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS study group (phase III). Journal of the Neurological Sciences, 169(1&#x2013;2), 13&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang JL, Lomen-Hoerth C, Murphy J, Henry RG, Kramer JH, Miller BL, &amp; Gorno-Tempini ML (2005). A voxel-based morphometry study of patterns of brain atrophy in ALS and ALS/FTLD. Neurology, 65(1), 75&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">16009889</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, et al. (2010). Neurobehavioral symptoms in ALS are negatively related to caregivers&#x2019; burden and quality of life. European Journal of Neurology, 17(10), 1298&#x2013;1303.</Citation><ArticleIdList><ArticleId IdType="pubmed">20402747</ArticleId></ArticleIdList></Reference><Reference><Citation>Chipika RH, Finegan E, Li Hi Shing S, Hardiman O, &amp; Bede P. (2019). Tracking a fast-moving disease: Longitudinal markers, monitoring, and clinical trial endpoints in ALS. Frontiers in Neurology, 10, 229.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6433752</ArticleId><ArticleId IdType="pubmed">30941088</ArticleId></ArticleIdList></Reference><Reference><Citation>Christidi F, Karavasilis E, Rentzos M, Kelekis N, Evdokimidis I, &amp; Bede P. (2018). Clinical and radiological markers of extra-motor deficits in amyotrophic lateral sclerosis. Frontiers in Neurology, 9, 1005.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6262087</ArticleId><ArticleId IdType="pubmed">30524366</ArticleId></ArticleIdList></Reference><Reference><Citation>Christidi F, Karavasilis E, Rentzos M, Velonakis G, Zouvelou V, Xirou S, Argyropoulos G, Papatriantafyllou I, Pantolewn V, Ferentinos P, Kelekis N, Seimenis I, Evdokimidis I, &amp; Bede P. (2019). Hippocampal pathology in amyotrophic lateral sclerosis: Selective vulnerability of subfields and their associated projections. Neurobiology of Aging, 84, 178&#x2013;188.</Citation><ArticleIdList><ArticleId IdType="pubmed">31629116</ArticleId></ArticleIdList></Reference><Reference><Citation>Christidi F, et al. (2020). Neuroimaging data indicate divergent mesial temporal lobe profiles in amyotrophic lateral sclerosis, Alzheimer&#x2019;s disease and healthy aging. Data Brief, 28, 104991.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6948121</ArticleId><ArticleId IdType="pubmed">31921944</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, &amp; Gornbein J. (1994). The neuropsychiatric inventory: Comprehensive assessment of psychopathology in dementia. Neurology, 44(12), 2308&#x2013;2314.</Citation><ArticleIdList><ArticleId IdType="pubmed">7991117</ArticleId></ArticleIdList></Reference><Reference><Citation>Desikan RS, S&#xe9;gonne F, Fischl B, Quinn BT, Dickerson BC, Blacker D, Buckner RL, Dale AM, Maguire RP, Hyman BT, Albert MS, &amp; Killiany RJ (2006). An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage, 31(3), 968&#x2013;980.</Citation><ArticleIdList><ArticleId IdType="pubmed">16530430</ArticleId></ArticleIdList></Reference><Reference><Citation>Devos D, Moreau C, Kyheng M, Gar&#xe7;on G, Rolland AS, Blasco H, Gel&#xe9; P, Timoth&#xe9;e Lenglet T, Veyrat-Durebex C, Corcia P, Dutheil M, Bede P, Jeromin A, Oeckl P, Otto M, Meininger V, Danel-Brunaud V, Devedjian JC, Duce JA, &amp; Pradat PF (2019). A ferroptosis-based panel of prognostic biomarkers for amyotrophic lateral sclerosis. Scientific Reports, 9(1), 2918.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6393674</ArticleId><ArticleId IdType="pubmed">30814647</ArticleId></ArticleIdList></Reference><Reference><Citation>Elamin M, Phukan J, Bede P, Jordan N, Byrne S, Pender N, &amp; Hardiman O. (2011). Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia. Neurology, 76(14), 1263&#x2013;1269.</Citation><ArticleIdList><ArticleId IdType="pubmed">21464431</ArticleId></ArticleIdList></Reference><Reference><Citation>Elamin M, Pinto-Grau M, Burke T, Bede P, Rooney J, O&#x2019;Sullivan M, Lonergan K, Kirby E, Quinlan E, Breen N, Vajda A, Heverin M, Pender N, &amp; Hardiman O. (2017). Identifying behavioural changes in ALS: Validation of the Beaumont Behavioural inventory (BBI). Amyotroph Lateral Scler Frontotemporal Degener, 18(1&#x2013;2), 68&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">27894191</ArticleId></ArticleIdList></Reference><Reference><Citation>Femiano C, et al. (2018). Apathy is correlated with widespread diffusion tensor imaging (DTI) impairment in amyotrophic lateral sclerosis. Behavioural Neurology, 2018, 2635202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6217902</ArticleId><ArticleId IdType="pubmed">30425751</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischl B. (2012). FreeSurfer. Neuroimage, 62(2), 774&#x2013;781.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3685476</ArticleId><ArticleId IdType="pubmed">22248573</ArticleId></ArticleIdList></Reference><Reference><Citation>Floeter MK, &amp; Gendron TF (2018). Biomarkers for amyotrophic lateral sclerosis and Frontotemporal dementia associated with Hexanucleotide expansion mutations in C9orf72. Frontiers in Neurology, 9, 1063.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6289985</ArticleId><ArticleId IdType="pubmed">30568632</ArticleId></ArticleIdList></Reference><Reference><Citation>Floeter MK, Bageac D, Danielian LE, Braun LE, Traynor BJ, &amp; Kwan JY (2016). Longitudinal imaging in C9orf72 mutation carriers: Relationship to phenotype. Neuroimage Clin, 12, 1035&#x2013;1043.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5153604</ArticleId><ArticleId IdType="pubmed">27995069</ArticleId></ArticleIdList></Reference><Reference><Citation>Floeter MK, Traynor BJ, Farren J, Braun LE, Tierney M, Wiggs EA, &amp; Wu T. (2017). Disease progression in C9orf72 mutation carriers. Neurology, 89(3), 234&#x2013;241.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5513817</ArticleId><ArticleId IdType="pubmed">28615433</ArticleId></ArticleIdList></Reference><Reference><Citation>Folstein MF, Folstein SE, &amp; McHugh PR (1975). &#x201c;mini-mental state&#x201d;. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12(3), 189&#x2013;198.</Citation><ArticleIdList><ArticleId IdType="pubmed">1202204</ArticleId></ArticleIdList></Reference><Reference><Citation>Grollemund V, Pradat PF, Querin G, Delbot F, le Chat G, PradatPeyre JF, &amp; Bede P. (2019). Machine learning in amyotrophic lateral sclerosis: Achievements, pitfalls, and future directions. Frontiers in Neuroscience, 13, 135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6403867</ArticleId><ArticleId IdType="pubmed">30872992</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu WT, Shelnutt M, Wilson A, Yarab N, Kelly C, Grossman M, Libon DJ, Khan J, Lah JJ, Levey AI, &amp; Glass J. (2013). Behavior matters&#x2013;cognitive predictors of survival in amyotrophic lateral sclerosis. PLoS One, 8(2), e57584.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3583832</ArticleId><ArticleId IdType="pubmed">23460879</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasper E, Schuster C, Machts J, Kaufmann J, Bittner D, Vielhaber S, Benecke R, Teipel S, &amp; Prudlo J. (2014). Microstructural white matter changes underlying cognitive and Behavioural impairment in ALS - an in vivo study using DTI. PLoS One, 9(12), e114543.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4263750</ArticleId><ArticleId IdType="pubmed">25501028</ArticleId></ArticleIdList></Reference><Reference><Citation>Koziol LF, Budding DE, &amp; Chidekel D. (2012). From movement to thought: Executive function, embodied cognition, and the cerebellum. The Cerebellum, 11(2), 505&#x2013;525.</Citation><ArticleIdList><ArticleId IdType="pubmed">22068584</ArticleId></ArticleIdList></Reference><Reference><Citation>Leslie FV, et al. (2014). Semantic deficits in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener, 16(1&#x2013;2): 46&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">25544644</ArticleId></ArticleIdList></Reference><Reference><Citation>Lillo P, Mioshi E, Burrell JR, Kiernan MC, Hodges JR, &amp; Hornberger M. (2012). Grey and white matter changes across the amyotrophic lateral sclerosis-frontotemporal dementia continuum. PLoS One, 7(8), e43993.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3430626</ArticleId><ArticleId IdType="pubmed">22952843</ArticleId></ArticleIdList></Reference><Reference><Citation>Machts J, Loewe K, Kaufmann J, Jakubiczka S, Abdulla S, Petri S, Dengler R, Heinze HJ, Vielhaber S, Schoenfeld MA, &amp; Bede P. (2015). Basal ganglia pathology in ALS is associated with neuropsychological deficits. Neurology, 85(15), 1301&#x2013;1309.</Citation><ArticleIdList><ArticleId IdType="pubmed">26385880</ArticleId></ArticleIdList></Reference><Reference><Citation>Massimo L, Powers C, Moore P, Vesely L, Avants B, Gee J, Libon DJ, &amp; Grossman M. (2009). Neuroanatomy of apathy and disinhibition in frontotemporal lobar degeneration. Dementia and Geriatric Cognitive Disorders, 27(1), 96&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2820577</ArticleId><ArticleId IdType="pubmed">19158440</ArticleId></ArticleIdList></Reference><Reference><Citation>Mioshi E, Lillo P, Yew B, Hsieh S, Savage S, Hodges JR, Kiernan MC, &amp; Hornberger M. (2013). Cortical atrophy in ALS is critically associated with neuropsychiatric and cognitive changes. Neurology, 80(12), 1117&#x2013;1123.</Citation><ArticleIdList><ArticleId IdType="pubmed">23427327</ArticleId></ArticleIdList></Reference><Reference><Citation>Mioshi E, Hsieh S, Caga J, Ramsey E, Chen K, Lillo P, Simon N, Vucic S, Hornberger M, Hodges JR, &amp; Kiernan MC (2014). A novel tool to detect behavioural symptoms in ALS. Amyotroph Lateral Scler Frontotemporal Degener, 15(3&#x2013;4), 298&#x2013;304.</Citation><ArticleIdList><ArticleId IdType="pubmed">24863641</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris JC (1997). Clinical dementia rating: A reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. International Psychogeriatrics, 9(Suppl 1), 173&#x2013;176 discussion 177&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">9447441</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy J, Ahmed F, &amp; Lomen-Hoerth C. (2015). The UCSF screening exam effectively screens cognitive and behavioral impairment in patients with ALS. Amyotroph Lateral Scler Frontotemporal Degener, 16(1&#x2013;2), 24&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">25301548</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy J, Factor-Litvak P, Goetz R, Lomen-Hoerth C, Nagy PL, Hupf J, Singleton J, Woolley S, Andrews H, Heitzman D, Bedlack RS, Katz JS, Barohn RJ, Sorenson EJ, Oskarsson B, Fernandes Filho JA, Kasarskis EJ, Mozaffar T, Rollins YD, Nations SP, Swenson AJ, Koczon-Jaremko BA, Mitsumoto H, &amp; ALS COSMOS. (2016). Cognitive-behavioral screening reveals prevalent impairment in a large multicenter ALS cohort. Neurology, 86(9), 813&#x2013;820.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4793785</ArticleId><ArticleId IdType="pubmed">26802094</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, McCluskey LF, Miller BL, Masliah E, Mackenzie IR, Feldman H, Feiden W, Kretzschmar HA, Trojanowski JQ, &amp; Lee VMY (2006). Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science, 314(5796), 130&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Callaghan C, Bertoux M, &amp; Hornberger M. (2013). Beyond and below the cortex: The contribution of striatal dysfunction to cognition and behaviour in neurodegeneration. Journal of Neurology, Neurosurgery, and Psychiatry, 85(4):371&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">23833269</ArticleId></ArticleIdList></Reference><Reference><Citation>Omer T, Finegan E, Hutchinson S, Doherty M, Vajda A, McLaughlin RL, Pender N, Hardiman O, &amp; Bede P. (2017). Neuroimaging patterns along the ALS-FTD spectrum: A multiparametric imaging study. Amyotroph Lateral Scler Frontotemporal Degener, 18(7&#x2013;8), 611&#x2013;623.</Citation><ArticleIdList><ArticleId IdType="pubmed">28562080</ArticleId></ArticleIdList></Reference><Reference><Citation>Pettit LD, Bastin ME, Smith C, Bak TH, Gillingwater TH, &amp; Abrahams S. (2013). Executive deficits, not processing speed relates to abnormalities in distinct prefrontal tracts in amyotrophic lateral sclerosis. Brain, 136(Pt 11), 3290&#x2013;3304.</Citation><ArticleIdList><ArticleId IdType="pubmed">24056536</ArticleId></ArticleIdList></Reference><Reference><Citation>Prell T, &amp; Grosskreutz J. (2013). The involvement of the cerebellum in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener, 14(7&#x2013;8), 507&#x2013;515.</Citation><ArticleIdList><ArticleId IdType="pubmed">23889583</ArticleId></ArticleIdList></Reference><Reference><Citation>Querin G, el Mendili MM, Bede P, Delphine S, Lenglet T, Marchand-Pauvert V, &amp; Pradat PF (2018). Multimodal spinal cord MRI offers accurate diagnostic classification in ALS. Journal of Neurology, Neurosurgery, and Psychiatry, 89(11), 1220&#x2013;1221.</Citation><ArticleIdList><ArticleId IdType="pubmed">29353238</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinn C, Elman L, McCluskey L, Hoskins K, Karam C, Woo JH, Poptani H, Wang S, Chawla S, Kasner SE, &amp; Grossman M. (2012). Frontal lobe abnormalities on MRS correlate with poor letter fluency in ALS. Neurology, 79(6), 583&#x2013;588.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3413764</ArticleId><ArticleId IdType="pubmed">22843269</ArticleId></ArticleIdList></Reference><Reference><Citation>Raaphorst J, Beeldman E, de Visser M, de Haan RJ, &amp; Schmand B. (2012a). A systematic review of behavioural changes in motor neuron disease. Amyotrophic Lateral Sclerosis, 13(6), 493&#x2013;501.</Citation><ArticleIdList><ArticleId IdType="pubmed">22424127</ArticleId></ArticleIdList></Reference><Reference><Citation>Raaphorst J, Beeldman E, Schmand B, Berkhout J, Linssen WHJP, van den Berg LH, Pijnenburg YA, Grupstra HF, Weikamp JG, Schelhaas HJ, Papma JM, van Swieten JC, de Visser M, &amp; de Haan RJ (2012b). The ALS-FTD-Q: A new screening tool for behavioral disturbances in ALS. Neurology, 79(13), 1377&#x2013;1383.</Citation><ArticleIdList><ArticleId IdType="pubmed">22972650</ArticleId></ArticleIdList></Reference><Reference><Citation>Radakovic R, Stephenson L, Colville S, Swingler R, Chandran S, &amp; Abrahams S. (2016). Multidimensional apathy in ALS: Validation of the dimensional apathy scale. Journal of Neurology, Neurosurgery, and Psychiatry, 87(6), 663&#x2013;669.</Citation><ArticleIdList><ArticleId IdType="pubmed">26203157</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajagopalan V, &amp; Pioro EP (2014). Distinct patterns of cortical atrophy in ALS patients with or without dementia: An MRI VBM study. Amyotroph Lateral Scler Frontotemporal Degener, 15(3&#x2013;4), 216&#x2013;225.</Citation><ArticleIdList><ArticleId IdType="pubmed">24555884</ArticleId></ArticleIdList></Reference><Reference><Citation>Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, van Swieten JC, Seelaar H, Dopper EGP, Onyike CU, Hillis AE, Josephs KA, Boeve BF, Kertesz A, Seeley WW, Rankin KP, Johnson JK, Gorno-Tempini ML, Rosen H, Prioleau-Latham CE, Lee A, Kipps CM, Lillo P, Piguet O, Rohrer JD, Rossor MN, Warren JD, Fox NC, Galasko D, Salmon DP, Black SE, Mesulam M, Weintraub S, Dickerson BC, Diehl-Schmid J, Pasquier F, Deramecourt V, Lebert F, Pijnenburg Y, Chow TW, Manes F, Grafman J, Cappa SF, Freedman M, Grossman M, &amp; Miller BL (2011). Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain, 134(Pt 9), 2456&#x2013;2477.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3170532</ArticleId><ArticleId IdType="pubmed">21810890</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen HJ, Allison SC, Schauer GF, Gorno-Tempini ML, Weiner MW, &amp; Miller BL (2005). Neuroanatomical correlates of behavioural disorders in dementia. Brain,128(Pt 11), 2612&#x2013;2625.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1820861</ArticleId><ArticleId IdType="pubmed">16195246</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarro L, Agosta F, Canu E, Riva N, Prelle A, Copetti M, Riccitelli G, Comi G, &amp; Filippi M. (2011). Cognitive functions and white matter tract damage in amyotrophic lateral sclerosis: A diffusion tensor tractography study. AJNR. American Journal of Neuroradiology, 32(10), 1866&#x2013;1872.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7966026</ArticleId><ArticleId IdType="pubmed">22016410</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster C, Kasper E, Dyrba M, Machts J, Bittner D, Kaufmann J, Mitchell AJ, Benecke R, Teipel S, Vielhaber S, &amp; Prudlo J. (2014). Cortical thinning and its relation to cognition in amyotrophic lateral sclerosis. Neurobiology of Aging, 35(1), 240&#x2013;246.</Citation><ArticleIdList><ArticleId IdType="pubmed">23992619</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster C, Elamin M, Hardiman O, &amp; Bede P. (2016a). The segmental diffusivity profile of amyotrophic lateral sclerosis associated white matter degeneration. European Journal of Neurology, 23(8), 1361&#x2013;1371.</Citation><ArticleIdList><ArticleId IdType="pubmed">27207250</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster C, Hardiman O, &amp; Bede P. (2016b). Development of an automated MRI-based diagnostic protocol for amyotrophic lateral sclerosis using disease-specific pathognomonic features: A quantitative disease-state classification study. PLoS One, 11(12), e0167331.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5132189</ArticleId><ArticleId IdType="pubmed">27907080</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster C, Hardiman O, &amp; Bede P. (2017). Survival prediction in amyotrophic lateral sclerosis based on MRI measures and clinical characteristics. BMC Neurology, 17(1), 73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5393027</ArticleId><ArticleId IdType="pubmed">28412941</ArticleId></ArticleIdList></Reference><Reference><Citation>Seeley WW, Crawford RK, Zhou J, Miller BL, &amp; Greicius MD (2009). Neurodegenerative diseases target large-scale human brain networks. Neuron, 62(1), 42&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2691647</ArticleId><ArticleId IdType="pubmed">19376066</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon N, &amp; Goldstein LH (2019). Screening for cognitive and behavioral change in amyotrophic lateral sclerosis/motor neuron disease: A systematic review of validated screening methods. Amyotroph Lateral Scler Frontotemporal Degener, 20(1&#x2013;2), 1&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">30585510</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith SM, Fox PT, Miller KL, Glahn DC, Fox PM, Mackay CE, Filippini N, Watkins KE, Toro R, Laird AR, &amp; Beckmann CF (2009). Correspondence of the brain&#x2019;s functional architecture during activation and rest. Proceedings of the National Academy of Sciences of the United States of America, 106(31), 13040&#x2013;13045.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2722273</ArticleId><ArticleId IdType="pubmed">19620724</ArticleId></ArticleIdList></Reference><Reference><Citation>Strata P, Scelfo B, &amp; Sacchetti B. (2011). Involvement of cerebellum in emotional behavior. Physiological Research, 60(Suppl 1), S39&#x2013;S48.</Citation><ArticleIdList><ArticleId IdType="pubmed">21777033</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong MJ, Grace GM, Freedman M, Lomen-Hoerth C, Woolley S, Goldstein LH, Murphy J, Shoesmith C, Rosenfeld J, Leigh PN, Bruijn L, Ince P, &amp; Figlewicz D. (2009). Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis, 10(3), 131&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pubmed">19462523</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuss DT, &amp; Alexander MP (2007). Is there a dysexecutive syndrome? Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 362(1481), 901&#x2013;915.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2430005</ArticleId><ArticleId IdType="pubmed">17412679</ArticleId></ArticleIdList></Reference><Reference><Citation>Touroutoglou A, Hollenbeck M, Dickerson BC, &amp; Feldman Barrett L. (2012). Dissociable large-scale networks anchored in the right anterior insula subserve affective experience and attention. Neuroimage, 60(4), 1947&#x2013;1958.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3345941</ArticleId><ArticleId IdType="pubmed">22361166</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsujimoto M, Senda J, Ishihara T, Niimi Y, Kawai Y, Atsuta N, Watanabe H, Tanaka F, Naganawa S, &amp; Sobue G. (2011). Behavioral changes in early ALS correlate with voxel-based morphometry and diffusion tensor imaging. Journal of the Neurological Sciences, 307(1&#x2013;2), 34&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">21641004</ArticleId></ArticleIdList></Reference><Reference><Citation>Weintraub S, Salmon D, Mercaldo N, Ferris S, Graff-Radford NR, Chui H, Cummings J, DeCarli C, Foster NL, Galasko D, Peskind E, Dietrich W, Beekly DL, Kukull WA, &amp; Morris JC (2009). The Alzheimer&#x2019;s disease Centers&#x2019; uniform data set (UDS): The neuropsychologic test battery. Alzheimer Disease and Associated Disorders, 23(2), 91&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2743984</ArticleId><ArticleId IdType="pubmed">19474567</ArticleId></ArticleIdList></Reference><Reference><Citation>Welsh RC, Jelsone-Swain LM, &amp; Foerster BR (2013). The utility of independent component analysis and machine learning in the identification of the amyotrophic lateral sclerosis diseased brain. Frontiers in Human Neuroscience, 7, 251.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3677153</ArticleId><ArticleId IdType="pubmed">23772210</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng HJ, Verstraete E, Walhout R, Schmidt R, Hendrikse J, Veldink JH, van den Heuvel MP, &amp; van den Berg LH (2015). Subcortical structures in amyotrophic lateral sclerosis. Neurobiology of Aging, 36(2), 1075&#x2013;1082.</Citation><ArticleIdList><ArticleId IdType="pubmed">25281019</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng HJ, Walhout R, Straathof M, Schmidt R, Hendrikse J, Veldink JH, van den Heuvel MP, &amp; van den Berg LH (2016). Widespread structural brain involvement in ALS is not limited to the C9orf72 repeat expansion. Journal of Neurology, Neurosurgery, and Psychiatry, 87(12), 1354&#x2013;1360.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5136726</ArticleId><ArticleId IdType="pubmed">27756805</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitwell JL, Jack CR, Senjem ML, &amp; Josephs KA (2006). Patterns of atrophy in pathologically confirmed FTLD with and without motor neuron degeneration. Neurology, 66(1), 102&#x2013;104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2752419</ArticleId><ArticleId IdType="pubmed">16401855</ArticleId></ArticleIdList></Reference><Reference><Citation>Woolley SC, Zhang Y, Schuff N, Weiner MW, &amp; Katz JS (2011). Neuroanatomical correlates of apathy in ALS using 4 tesla diffusion tensor MRI. Amyotrophic Lateral Sclerosis, 12(1), 52&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">21271791</ArticleId></ArticleIdList></Reference><Reference><Citation>Yunusova Y, Plowman EK, Green JR, Barnett C, &amp; Bede P. (2019). Clinical measures of bulbar dysfunction in ALS. Frontiers in Neurology, 10, 106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6389633</ArticleId><ArticleId IdType="pubmed">30837936</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamboni G, Huey ED, Krueger F, Nichelli PF, &amp; Grafman J. (2008). Apathy and disinhibition in frontotemporal dementia: Insights into their neural correlates. Neurology, 71(10), 736&#x2013;742.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2676948</ArticleId><ArticleId IdType="pubmed">18765649</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>